MDCPartners provides evidence to help pharmaceutical companies make better decisions. Whether optimizing study placement or selecting research partners, our technologies bridge the information gaps in today’s competitive clinical research space. MDCPartners have developed ta-Scan, an innovative online system to classify individuals and their research relationships. ta-scan can analyze KOL relationships, identifying investigators with therapeutic experience or an institute with the necessary capabilities to conduct a complex protocol. It delivers powerful insights without the need to navigate dozens of databases. ta-Scan breaks down the global and national therapeutic landscape into an easily navigable experience.
A challenge for global organizations is to have actionable and trustworthy information available. ta-scan offers a cohesive information delivery solution by monitoring all sponsor and trial aspects through thousands of public disclosures over multiple territories. Through our unique technology we semantically structure, aggregate and display worldwide data to help organizations assess their clinical footprint and develop strategies based on evidence.
ta-Scan provides data via a web enabled graphic user interface. The ta-Scan browser provides a comprehensive view on a therapy area. You can purchase a license for one or a cluster of indications. ta-scan not only offers a window on global clinical research activity but is refreshed regularly and can monitor and alert users to specific changes in an interest area.
The Clinical Developer
Make evidence based decisions that compliment your feasibility assumptions and confirm third party proposals. Exploit the global clinical transparency age and get the latest information without waiting.
The Marketer
Get a global view, understand the competitive landscape and health policies that influence your marketing targets. Analyze and model with accurate pipeline data and regional standards of care. ta-Scan has developed many graphic treatments tuned for todays information hungry executive. Updated regularly, a profile of your relevant therapy areas can be generated to produce custom reports.
The Project Manager
The complexity of many new treatment scenarios has intensified rivalry for clinical centres. This environment has led to companies initiating studies beyond their traditional boundaries and challenges organization informational resources. ta-scan helps you assess territories outside which can be outside your comfort zone. We can help identify individuals or an organization with a specific research pedigree.
Return to Overview Business intelligence for the pharmaceutical sector
Sign up for our free quarterly newsletter which gives the latest information on our activities, products and market developments.
MDCPartners respects your privacy. You can unsubscribe anytime.